Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 314,000 | 302,000 | 266,000 | 298,000 | 307,000 |
| Cost of Goods | 83,000 | 52,000 | 44,000 | 48,000 | 66,000 |
| Gross Profit | 230,000 | 250,000 | 221,000 | 250,000 | 241,000 |
| Operating Expenses | 187,000 | 179,000 | 155,000 | 211,000 | 205,000 |
| Operating Income | 43,000 | 72,000 | 66,000 | 40,000 | 35,000 |
| Interest Expense | 12,000 | 15,000 | 12,000 | 12,000 | 11,000 |
| Other Income | 6,000 | 5,000 | 5,000 | 4,000 | 6,000 |
| Pre-tax Income | 37,000 | 62,000 | 59,000 | 32,000 | 30,000 |
| Income Tax | -5,000 | 44,000 | 11,000 | 15,000 | 8,000 |
| Net Income Continuous | 42,000 | 18,000 | 47,000 | 16,000 | 22,000 |
| Net Income | $42,000 | $18,000 | $47,000 | $16,000 | $22,000 |
| EPS Basic Total Ops | 0.34 | 0.15 | 0.38 | 0.13 | 0.16 |
| EPS Basic Continuous Ops | 0.34 | 0.14 | 0.38 | 0.12 | 0.17 |
| EPS Diluted Total Ops | 0.33 | 0.14 | 0.38 | 0.13 | 0.16 |
| EPS Diluted Continuous Ops | 0.33 | 0.14 | 0.38 | 0.12 | 0.17 |
| EPS Diluted Before Non-Recurring Items | 0.72 | 0.51 | 0.41 | 0.32 | 0.54 |
| EBITDA(a) | $49,000 | $76,000 | $72,000 | $49,000 | $44,000 |